Home
University of Bergen
August Bakke's picture

August Bakke

Professor Emeritus
Department of Clinical Medicine
  • E-mailAugust.Bakke@uib.no
  • Phone+47 55 97 27 56
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2016). Preventing Complications - The Preflight Checklist. European Urology Focus. 60-62.
  • Show author(s) (2016). Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
  • Show author(s) (2015). Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian Journal of Urology. 282-289.
  • Show author(s) (2010). Voiding disorders among children and adolescents: surveillance after voiding school treatment. International Journal of Urological Nursing. 22-32.
  • Show author(s) (2010). Pad per day usage, urinary incontinence and urinary tract infections in nursing home residents. Age and Ageing. 549-554.
  • Show author(s) (2008). Residual urine as a risk factor for lower urinary tract infection: A 1-year follow-up study in nursing homes. Journal of The American Geriatrics Society. 871-874.
  • Show author(s) (2008). Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. 1257-1264.
  • Show author(s) (2007). Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy. Scandinavian Journal of Urology and Nephrology. 191-197.
  • Show author(s) (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis. 106-112.
  • Show author(s) (2007). Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis. 106-112.
  • Show author(s) (2006). Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study. BJU International. 698-702.
  • Show author(s) (2006). A concomitant tumour boost in bladder irradiation: Patient suitability and the potential of intensity-modulated radiotherapy. Radiotherapy and Oncology. 98-105.
  • Show author(s) (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. International Journal of Oncology. 329-336.
  • Show author(s) (2004). The Potentially Curable Prostate Cancer Patient and the Pathways Leading to Diagnosis and Treatment. Scandinavian Journal of Urology and Nephrology. 15-18.
  • Show author(s) (2004). Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. International Journal of Radiation Oncology, Biology, Physics. 476-482.
  • Show author(s) (2001). Vannlatingsproblemer og urinveiskomplikasjoner hos ungdom og voksne med myelomeningocele. Tidsskrift for Den norske legeforening. 1211-5.
  • Show author(s) (2001). Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Show author(s) (2001). Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Show author(s) (2001). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Show author(s) (2001). Reduced quality of life among MS patients with sexual disturbance and bladder dysfunction. Multiple Sclerosis. 231-235.
  • Show author(s) (2001). Reconstructive urology in the nordic countries - a hospital questionnaire survey. Scandinavian Journal of Urology and Nephrology. 186-9.
  • Show author(s) (2001). Oppfølgning av urinveisproblemer hos voksne med myelomeningocele. Tidsskrift for Den norske legeforening. 1247-51.
  • Show author(s) (1998). Psychological predictors of symptoms of urinary tract infection and bacteriuria in patients treated with clean intermittent catheterization. European Urology. 30-36.
  • Show author(s) (1997). Utredning og oppfølgning ved BPH. Nytt om legemidler forts. av: Nytt fra Statens legemiddelkontroll. 19-20.
  • Show author(s) (1997). Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. British Journal of Urology. 85-90.
  • Show author(s) (1997). Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. British Journal of Urology. 85-90.
  • Show author(s) (1997). Perforation of continent urinary reservoirs - Scandinavian experience. Scandinavian Journal of Urology and Nephrology. 529-532.
  • Show author(s) (1997). Inhibition of mitogen-induced lymphoproliferation by soluble annexin II in sera from patients with renal carcinoma. APMIS - Journal of Pathologiy, Microbiology and Immunology. 699-704.
  • Show author(s) (1996). Urinveisinfeksjon hos pasienter behandlet med selvkateterisering. En prevalensundersøkelse av pasienter på langtids ren intermitterende kateterisering. Tidsskrift for Den norske legeforening. 2552-2555.
  • Show author(s) (1996). Urinveisinfeksjon hos pasienter behandlet med selvkateterisering. En prevalens undersøkelse av pasienter på langtids ren intermitterende kateterisering. Tidsskrift for Den norske legeforening. 2552-2555.
  • Show author(s) (1996). Tamsulosin, the First Prostate-Selective _a1A-Adrenoceptor Antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic Obstruction (Symptomatic BPH). European Urology. 145-154.
  • Show author(s) (1996). Tamsulosin, the First Prostate-Selective _a1A-Adrenoceptor Antagonist. A Meta-analysis of two randomized placebo-controlled, multicentre studies in patients with benign prostatic obstruction (Symptomatic BPH). European Urology. 155-167.
  • Show author(s) (1996). Bladder, bowel and sexual dysfunction in patients with multiple sclerosis - a cohort study. Scandinavian Journal of Urology and Nephrology. 61-66.
  • Show author(s) (1996). Bladder, bowel and sexual dysfunction in patients with multiple sclerosis - a cohort study. Scandinavian Journal of Urology and Nephrology. 61-66.
  • Show author(s) (1995). Ureteroscopy in pregnancy. Journal of Urology. 1660-1663.
  • Show author(s) (1994). Psychosocial adjustment to illness scale (PAIS-SR) in a Norwegian material of patients with functional dyspepsia, duodenal ulcer, and urinary bladder dysfunction. Scandinavian Journal of Gastroenterology. 611-617.
  • Show author(s) (1994). Normalisering av blæretømmingen hos pasienter på ren intermitterende katerisering. Nordisk Medicin. 56-57.
  • Show author(s) (1994). Clean intermittent catheterization in lower urinary tract dysfunction - an overview. Scandinavian Journal of Urology and Nephrology. 55-60.
  • Show author(s) (1993). Social functioning and general well-being in patients treated with clean intermittent catheterization. Journal of Psychosomatic Research. 371-380.
  • Show author(s) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
  • Show author(s) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
  • Show author(s) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. Journal of Urology. 527-531.
  • Show author(s) (1993). Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catherisation. Journal of Urology. 527-531.
  • Show author(s) (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Show author(s) (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Show author(s) (1993). Physical complications in patients treated with clean intermittent catheterization. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Show author(s) (1993). Physical complications in patients treated with clean intermittent catheterisation. Scandinavian Journal of Urology and Nephrology. 55-61.
  • Show author(s) (1993). Clean intermittent catheterization. Physical and psychological complications. J Urol Nephrol. Suppl. 1-69.
  • Show author(s) (1993). Clean intermittent catheterization-performing abilities, aversive experiences and distress. Paraplegia. 288-297.
  • Show author(s) (1993). Clean intermittent catheterization - performing abilities, aversive experiences and distress. International Medical Society of Paraplegia. 288-297.
  • Show author(s) (1993). Clean intermittent catheterisation - performing abilities, aversive experiences and distress. Paraplegia. 288-297.
  • Show author(s) (1992). What is the requirement of clean intermittent catheterization? - An epidemiologic study. Neurourology and Urodynamics. 414-415.
  • Show author(s) (1992). Physical complications and their risk factors in patients treated with clean intermittent catheterization. Neurourology and Urodynamics. 412-413.
  • Show author(s) (1992). Incidence of improvement of bladder emptying in 1702 patients on clean intermittent catheterization. Neurourology and Urodynamics. 411-412.
  • Show author(s) (1992). Clinical background of patients treated with cleanintermittent catherization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
  • Show author(s) (1992). Clinical background of patients treated with clean intermittent catheterization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
  • Show author(s) (1992). Clinical background of patients treated with clean intermittent catherization in Norway. Scandinavian Journal of Urology and Nephrology. 211-217.
  • Show author(s) (1991). Urinary tract infection in patients treated with clean intermittent catheterization - predictive variables. Scandinavian Journal of Urology and Nephrology. 76-77.
  • Show author(s) (1991). Quality of life and discomfort in patients with clean intermittent catheterization. Neurourology and Urodynamics. 305-306.
  • Show author(s) (1991). Clinical background of patients treated with clean intermittent catheterization in Norway. Scandinavian Journal of Urology and Nephrology.
  • Show author(s) (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
  • Show author(s) (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
  • Show author(s) (1991). Bacteriuria in patients treated with clean intermittent catheterization. Scandinavian Journal of Infectious Diseases. 577-582.
  • Show author(s) (1985). Screening for hematuria, glucosuria and proteinuria in people aged 55-64. Scandinavian Journal of Primary Health Care. 31-34.
Academic lecture
  • Show author(s) (2005). A concomitant tumour boost in bladder irradiation: Patient suitability and the potensial of intensity-modulated radiotherapy.
  • Show author(s) (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.
  • Show author(s) (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays.
  • Show author(s) (2003). Global analysis of gene expression and regulatory patterns in cancer.
  • Show author(s) (2003). Gene expression profiling in prostate cancer: Cluster analysis and association with tumor differentiation.
  • Show author(s) (2003). Gene expression profiling in prostate cancer.
  • Show author(s) (2003). DNA microarray studies of human cancer - pitfalls and outlook.
  • Show author(s) (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer.
  • Show author(s) (2002). Genital selvmutilering (GSM) - ren skjær galskap eller .. ?
  • Show author(s) (2000). Survival after radical nephrectomy for renal cell carcinoma in 103 patients.
Editorial
  • Show author(s) (2020). Når barn ikke får kontroll med vannlatingen. Tidsskrift for Den norske legeforening. 1-2.
Masters thesis
  • Show author(s) (2008). Uroterapi til barn og unge -hvor står vi ? -hvor går vi?
Doctoral dissertation
  • Show author(s) (2015). Time relations of biological markers in urothelial carcinomas.
  • Show author(s) (2015). Health-related Quality of Life, Distress and Psychosocial Factors in Head and Neck and Renal Cancer Patients. Quality of Life in HNSCC and RCC patients.
  • Show author(s) (1992). Clean intermittent catheterization - physical and psychological complications.
Academic chapter/article/Conference paper
  • Show author(s) (1997). Treatment of BPH - the primary evaluation and follow-up procedures.
  • Show author(s) (1991). Urinveisforstyrrelser. 15 pages.
Abstract
  • Show author(s) (2009). Residual Urine as a Risk Factor for Lower Urinary Tract Infection: A 1-Year Follow-Up Study in Nursing Homes. Journal of Urology. 1139-1139.
Poster
  • Show author(s) (2003). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue.

More information in national current research information system (CRIStin)